Roundtable Discussion: COVID-19 Impact on MedTech
The COVID-19 pandemic has had a significant impact – both positive and negative – on MedTech customers as well as the MedTech industry itself. Similar to how...
Dr. Myriam Mirza is an associate principal in the Life Sciences Practice of CRA. She has over seven years consulting experience in the life sciences field including healthcare, medical devices, pharmaceuticals, and non-profits.
Prior to joining CRA, Dr. Mirza was a freelance senior healthcare strategic consultant and analyst where she managed teams across the US to implement rare disease clinical programs and consulting European and US clients on market entry, access, and expansion strategies. She has presented at board meetings, international conferences, and has been invited as a rare disease keynote speaker on numerous occasions.